Keyphrases
Clinical Trials
100%
Minocycline
100%
Randomized Double-blind
100%
Early Parkinson's Disease
100%
Parkinson's Disease
85%
Vitamin E
57%
Parkinsonism
42%
Antioxidant Therapy
42%
Deprenyl
42%
Placebo Groups
28%
Placebo
28%
Phase II Trial
28%
Tolerability
28%
Unified Parkinson's Disease Rating Scale (UPDRS)
28%
Adverse Events
14%
Nausea
14%
Upper Respiratory Tract Infection
14%
Two-agent
14%
Progression Rate
14%
Sensitivity Analysis
14%
Phase II Clinical Trial
14%
Disability
14%
Historical Controls
14%
Long-term Development
14%
Symptomatic Therapy
14%
Activity-based Costing
14%
Joint Pain
14%
Systematic Evaluation
14%
Disease-modifying Therapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Parkinson's Disease
100%
Minocycline
100%
Placebo
40%
Tocopherol
40%
Antioxidant
30%
Parkinsonism
30%
Selegiline
30%
Tolerability
20%
Diseases
10%
Adverse Event
10%
Nausea
10%
Arthralgia
10%